France Refines Early Access System Again
Significant Benefits Seen For Patients With No Other Options
Executive Summary
Following last year’s reform of the scheme that allows early access to unapproved or non-reimbursed medicines, the rules are being changed again, including the criteria used to determine whether an “appropriate treatment” is already available.